You can see why we're hustling to get an OM deal. The market is not giving us affordable capital and AS wasn't willing to give us much upfront for just UP. Remember the predictions that it was millions? Objectivity and reason always prevail.
The company has little apparent to announce in the meantime. The UC phase 1 will kick off soon, but that is not news. The K pill is on hold. I'm not sure we'll see any clinical kick off for OM without a partner. I'm keeping watch for a term sheet announcement.
Market Data 
Markets 
AI
